{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:54:38Z","timestamp":1791388478064,"version":"4.3.3"},"reference-count":133,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Chronic coronary syndrome (CCS), which encompasses a broad spectrum of clinical presentations of coronary artery disease (CAD), is the leading cause of morbidity and mortality worldwide. Recent guidelines for the management of CCS emphasize the dynamic nature of the CAD process, replacing the term \u201cstable\u201d with \u201cchronic\u201d, as this disease is never truly \u201cstable\u201d. Despite significant advances in the treatment of CAD, patients with CCS remain at an elevated risk of major cardiovascular events (MACE) due to the so-called residual cardiovascular risk. Several pathogenetic pathways (thrombotic, inflammatory, metabolic, and procedural) may distinctly contribute to the residual risk in individual patients and represent a potential target for newer preventive treatments. Identifying the level and type of residual cardiovascular risk is essential for selecting the most appropriate diagnostic tests and follow-up procedures. In addition, new management strategies and healthcare models could further support available treatments and lead to important prognostic benefits. This review aims to provide an overview of the diagnostic and therapeutic challenges in the management of patients with CCS and to promote more effective multidisciplinary care.<\/jats:p>","DOI":"10.3390\/jcm12185989","type":"journal-article","created":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T23:32:27Z","timestamp":1694993547000},"page":"5989","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Management of Residual Risk in Chronic Coronary Syndromes. Clinical Pathways for a Quality-Based Secondary Prevention"],"prefix":"10.3390","volume":"12","author":[{"given":"Simona","family":"Giubilato","sequence":"first","affiliation":[{"name":"Cardiology Department, Cannizzaro Hospital, 95126 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5369-5382","authenticated-orcid":false,"given":"Fabiana","family":"Luc\u00e0","sequence":"additional","affiliation":[{"name":"Cardiology Department, Grande Ospedale Metropolitano, AO Bianchi Melacrino Morelli, 89129 Reggio Calabria, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0237-7157","authenticated-orcid":false,"given":"Maurizio Giuseppe","family":"Abrignani","sequence":"additional","affiliation":[{"name":"Operative Unit of Cardiology, P. Borsellino Hospital, 91025 Marsala, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Gatto","sequence":"additional","affiliation":[{"name":"Cardiology Department, San Giovanni Addolorata Hospital, 00184 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo Massimiliano","family":"Rao","sequence":"additional","affiliation":[{"name":"Cardiology Department, Grande Ospedale Metropolitano, AO Bianchi Melacrino Morelli, 89129 Reggio Calabria, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Ingianni","sequence":"additional","affiliation":[{"name":"ASP Trapani Cardiologist Marsala Castelvetrano Districts, 91022 Castelvetrano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Amico","sequence":"additional","affiliation":[{"name":"Cardiology Department, Cannizzaro Hospital, 95126 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Rossini","sequence":"additional","affiliation":[{"name":"Cardiology Unit, Ospedale Santa Croce e Carle, 12100 Cuneo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Caretta","sequence":"additional","affiliation":[{"name":"Sant\u2019Andrea Hospital, ASL 5 Regione Liguria, 19124 La Spezia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4311-2139","authenticated-orcid":false,"given":"Stefano","family":"Cornara","sequence":"additional","affiliation":[{"name":"Arrhytmia Unit, Division of Cardiology, Ospedale San Paolo, Azienda Sanitaria Locale 2, 17100 Savona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Di Matteo","sequence":"additional","affiliation":[{"name":"De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8925-6149","authenticated-orcid":false,"given":"Concetta","family":"Di Nora","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Science, Azienda Sanitaria Universitaria Integrata di Udine, 33100 Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Favilli","sequence":"additional","affiliation":[{"name":"Department of Pediatric Cardiology, Meyer Hospital, 50139 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pilleri","sequence":"additional","affiliation":[{"name":"Cardiology Unit, Brotzu Hospital, 09121 Cagliari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pozzi","sequence":"additional","affiliation":[{"name":"Cardiology Department, Papa Giovanni XXIII Hospital, 24127 Bergamo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Luigi","family":"Temporelli","sequence":"additional","affiliation":[{"name":"Division of Cardiac Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS, 28013 Gattico-Veruno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4559-1292","authenticated-orcid":false,"given":"Marco","family":"Zuin","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy"},{"name":"Department of Cardiology, West Vicenza Hospital, 136071 Arzignano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Francesco","family":"Amico","sequence":"additional","affiliation":[{"name":"CCU-Cardiology Unit, Ospedale San Giuseppe da Copertino Hospital, Copertino, 73043 Lecce, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Riccio","sequence":"additional","affiliation":[{"name":"Cardiovascular Department, Sant\u2019Anna e San Sebastiano Hospital, 81100 Caserta, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9347-8884","authenticated-orcid":false,"given":"Massimo","family":"Grimaldi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, General Regional Hospital \u201cF. Miulli\u201d, 70021 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7187-2234","authenticated-orcid":false,"given":"Furio","family":"Colivicchi","sequence":"additional","affiliation":[{"name":"Clinical and Rehabilitation Cardiology Unit, San Filippo Neri Hospital, 00135 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Oliva","sequence":"additional","affiliation":[{"name":"De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele Massimo","family":"Gulizia","sequence":"additional","affiliation":[{"name":"Cardiology Department, Garibaldi Nesima Hospital, 95122 Catania, Italy"},{"name":"Heart Care Foundation, 50121 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1016\/j.jacc.2023.03.410","article-title":"ACC\/AHA\/ASE\/ASNC\/ASPC\/HFSA\/HRS\/SCAI\/SCCT\/SCMR\/STS 2023 Multimodality Appropriate Use Criteria for the Detection and Risk Assessment of Chronic Coronary Disease","volume":"81","author":"Winchester","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global Burden of Cardiovascular Diseases and Risk Factors, 1990\u20132019: Update from the GBD 2019 Study","volume":"76","author":"Roth","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/eurheartj\/ehz660","article-title":"Long-term outcomes of chronic coronary syndrome worldwide: Insights from the international CLARIFY registry","volume":"41","author":"Sorbets","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_5","first-page":"e38","article-title":"Heart Disease and Stroke Statistics-2016 Update: A Report from the American Heart Association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/ehjqcco\/qcz057","article-title":"The ESC-EORP Chronic Ischaemic Cardiovascular Disease Long Term (CICD LT) registry","volume":"7","author":"Komajda","year":"2019","journal-title":"Eur. Heart J.\u2014Qual. Care Clin. Outcomes"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/eurjpc\/zwac089","article-title":"Impact of chronic coronary syndromes on cardiovascular hospitalization and mortality: The ESC-EORP CICD-LT registry","volume":"29","author":"Kerneis","year":"2022","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1093\/eurheartj\/ehs289","article-title":"Women and men with stable coronary artery disease have similar clinical outcomes: Insights from the international prospective CLARIFY registry","volume":"33","author":"Steg","year":"2012","journal-title":"Eur. Heart J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ahj.2003.11.028","article-title":"Effect of age on the use of evidence-based therapies for acute myocardial infarction","volume":"148","author":"Tran","year":"2004","journal-title":"Am. Heart J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/ehjqcco\/qcab015","article-title":"Thirteen-year trends in cardiovascular risk in men and women with chronic coronary syndrome","volume":"8","author":"Olesen","year":"2022","journal-title":"Eur. Heart J.\u2014Qual. Care Clin. Outcomes"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1093\/eurheartj\/ehx515","article-title":"Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: Experiences from the SWEDEHEART registry 1995\u20132014","volume":"38","author":"Szummer","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1093\/eurheartj\/ehy554","article-title":"Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: Experiences from SWEDEHEART registry 1995 to 2014","volume":"39","author":"Szummer","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","article-title":"Long-term use of ticagrelor in patients with prior myocardial infarction","volume":"372","author":"Bonaca","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents","volume":"371","author":"Mauri","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/jama.297.11.1197","article-title":"One-Year Cardiovascular Event Rates in Outpatients With Atherothrombosis","volume":"297","author":"Steg","year":"2007","journal-title":"JAMA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/eurheartj\/ehu505","article-title":"Cardiovascular risk in post-myocardial infarction patients: Nationwide real world data demonstrate the importance of a long-term perspective","volume":"36","author":"Jernberg","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1093\/eurheartj\/ehq326","article-title":"Underestimated and under-recognized: The late consequences of acute coronary syndrome (GRACE UK-Belgian Study)","volume":"31","author":"Fox","year":"2010","journal-title":"Eur. Heart J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/eurheartj\/ehr331","article-title":"Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events","volume":"33","author":"Jespersen","year":"2012","journal-title":"Eur. Heart J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ahj.2013.03.015","article-title":"Sex differences in clinical outcomes in patients with stable angina and no obstructive coronary artery disease","volume":"166","author":"Sedlak","year":"2013","journal-title":"Am. Heart J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.jcin.2018.05.005","article-title":"Prognostic Implication of Thermodilution Coronary Flow Reserve in Patients Undergoing Fractional Flow Reserve Measurement","volume":"11","author":"Lee","year":"2018","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/j.jacc.2010.01.054","article-title":"Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women s Ischemia. Syndrome Evaluation) study","volume":"55","author":"Pepine","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/CIRCULATIONAHA.112.120402","article-title":"Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus","volume":"126","author":"Murthy","year":"2012","journal-title":"Circulation"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/HCO.0000000000000998","article-title":"Myocardial infarction with nonobstructive coronary arteries: The need for precision medicine","volume":"37","author":"Rinaldi","year":"2022","journal-title":"Curr. Opin. Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Bryniarski, K., Gasior, P., Legutko, J., Makowicz, D., Kedziora, A., Szolc, P., Bryniarski, L., Kleczynski, P., and Jang, I.-K. (2021). OCT Findings in MINOCA. J. Clin. Med., 10.","DOI":"10.3390\/jcm10132759"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Borzillo, I., De Filippo, O., Manai, R., Bruno, F., Ravetti, E., Galanti, A.A., Vergallo, R., Porto, I., De Ferrari, G.M., and D\u2019ascenzo, F. (2023). Role of Intracoronary Imaging in Myocardial Infarction with Non-Obstructive Coronary Disease (MINOCA): A Review. J. Clin. Med., 12.","DOI":"10.3390\/jcm12062129"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Gudigar, A., Nayak, S., Samanth, J., Raghavendra, U.A.J.A., Barua, P.D., Hasan, N., Ciaccio, E.J., Tan, R.-S., and Acharya, U.R. (2021). Recent Trends in Artificial Intelligence-Assisted Coronary Atherosclerotic Plaque Characterization. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph181910003"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/S0735-1097(03)01057-X","article-title":"Predictors of late development of heart failure in stable survivors of myocardial infarction: The CARE study","volume":"42","author":"Lewis","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1161\/CIRCHEARTFAILURE.108.820696","article-title":"Predictors of heart failure in patients with stable coronary artery disease: A PEACE study","volume":"2","author":"Lewis","year":"2009","journal-title":"Circ. Heart Fail."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.amjcard.2013.12.019","article-title":"Prognosis of patients with stable coronary artery disease (from the CORONOR study)","volume":"113","author":"Bauters","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.cardfail.2018.09.013","article-title":"First Hospitalization for Heart Failure in Outpatients with Stable Coronary Artery Disease: Determinants, Role of Incident Myocardial Infarction, and Prognosis","volume":"24","author":"Lamblin","year":"2018","journal-title":"J. Card. Fail."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fcvm.2020.00088","article-title":"The Evolving Understanding and Approach to Residual Cardiovascular Risk Management","volume":"7","author":"Dhindsa","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e007174","DOI":"10.1161\/JAHA.117.007174","article-title":"Culprit and Nonculprit Recurrent Ischemic Events in Patients with Myocardial Infarction: Data From SWEDEHEART (Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies)","volume":"7","author":"Varenhorst","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.2016.3775","article-title":"Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention","volume":"315","author":"Yeh","year":"2016","journal-title":"JAMA"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jcin.2019.12.018","article-title":"DAPT Score and the Impact of Ticagrelor Monotherapy During the Second Year After PCI","volume":"13","author":"Chichareon","year":"2020","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jacc.2018.06.023","article-title":"External Validation of the DAPT Score in a Nationwide Population","volume":"72","author":"Ueda","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1055\/s-0040-1721145","article-title":"DAPT Score to Stratify Ischemic and Bleeding Risk after Percutaneous Coronary Intervention: An Updated Systematic Review, Meta-Analysis, and Meta-Regression of 100,211 Patients","volume":"121","author":"Montalto","year":"2021","journal-title":"Thromb. Haemost."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0140-6736(17)30397-5","article-title":"Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: A pooled analysis of individual-patient datasets from clinical trials","volume":"389","author":"Costa","year":"2017","journal-title":"Lancet"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/ehjcvp\/pvab080","article-title":"The association of PRECISE-DAPT score with ischaemic outcomes in patients taking dual antiplatelet therapy following percutaneous coronary intervention: A meta-analysis","volume":"8","author":"Clifford","year":"2022","journal-title":"Eur. Heart J.\u2014Cardiovasc. Pharmacother."},{"key":"ref_42","first-page":"1175","article-title":"Combined association of key risk factors on ischaemic outcomes and bleeding in patients with myocardial infarction","volume":"105","author":"Lindholm","year":"2019","journal-title":"Heart"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/jama.2010.1322","article-title":"Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis","volume":"304","author":"Bhatt","year":"2010","journal-title":"JAMA"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1002358","article-title":"A Prospective Natural-History Study of Coronary Atherosclerosis","volume":"364","author":"Stone","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/eurheartj\/ehz520","article-title":"Relationship between coronary plaque morphology of the left anterior descending artery and 12 months clinical outcome: The CLIMA study","volume":"41","author":"Prati","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/CIRCULATIONAHA.109.891523","article-title":"Association of Diet, Exercise, and Smoking Modification with Risk of Early Cardiovascular Events after Acute Coronary Syndromes","volume":"121","author":"Chow","year":"2010","journal-title":"Circulation"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.amjcard.2014.03.033","article-title":"Effect of Sustaining Lifestyle Modifications (Nonsmoking, Weight Reduction, Physical Activity, and Mediterranean Diet) after Healing of Myocardial Infarction, Percutaneous Intervention, or Coronary Bypass (from the REasons for Geographic and Racial Differences in Stroke Study)","volume":"113","author":"Booth","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"21942204","DOI":"10.1001\/archinte.168.20.2194","article-title":"Global secondary prevention strategies to limit event recurrence after myocardial infarction: Results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network","volume":"168","author":"Giannuzzi","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/S0140-6736(08)60868-5","article-title":"Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: A paired, cluster-randomised controlled trial","volume":"371","author":"Wood","year":"2008","journal-title":"Lancet"},{"key":"ref_51","first-page":"CD005050","article-title":"Influenza vaccines for preventing cardiovascular disease","volume":"5","author":"Clar","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e017112","DOI":"10.1161\/JAHA.120.017112","article-title":"JAHA Spotlight on Psychosocial Factors and Cardiovascular Disease","volume":"9","author":"Peterson","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1161\/01.CIR.99.16.2192","article-title":"Impact of Psychological Factors on the Pathogenesis of Cardiovascular Disease and Implications for Therapy","volume":"99","author":"Rozanski","year":"1999","journal-title":"Circulation"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/CIRCRESAHA.121.319811","article-title":"Social Determinants of Cardiovascular Disease","volume":"130","author":"Baumer","year":"2022","journal-title":"Circ. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/2047487317739978","article-title":"Psychological interventions for coronary heart disease: Cochrane systematic review and meta-analysis","volume":"25","author":"Richards","year":"2018","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/PSY.0b013e318291d798","article-title":"A Meta-Analysis of Mental Health Treatments and Cardiac Rehabilitation for Improving Clinical Outcomes and Depression among Patients with Coronary Heart Disease","volume":"75","author":"Rutledge","year":"2013","journal-title":"Psychosom. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1161\/CIRCULATIONAHA.113.006218","article-title":"Blood pressure management in the 21st century: Maximizing gains and minimizing waste","volume":"128","author":"Rahimi","year":"2013","journal-title":"Circulation"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: A systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1056\/NEJMoa1303154","article-title":"Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy","volume":"369","author":"Fried","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"42","author":"Collet","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41569-019-0314-y","article-title":"Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease","volume":"17","author":"Capodanno","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa1908077","article-title":"Ticagrelor in Patients with Stable Coronary Disease and Diabetes","volume":"381","author":"Steg","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0140-6736(19)31887-2","article-title":"Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): A phase 3, placebo-controlled, randomised trial","volume":"394","author":"Bhatt","year":"2019","journal-title":"Lancet"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S0140-6736(18)31858-0","article-title":"Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: A multicentre, open-label, randomised superiority trial","volume":"392","author":"Vranckx","year":"2018","journal-title":"Lancet"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Cholesterol Treatment Trialists\u2019 (CTT) Collaboration, Baigent, C., Blackwell, L., Emberson, J., Holland, L.E., Reith, C., Bhala, N., Peto, R., Barnes, E.H., and Keech, A. (2010). Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet, 376, 16701681.","DOI":"10.1016\/S0140-6736(10)61350-5"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","article-title":"Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: A European Atherosclerosis Society consensus statement","volume":"43","author":"Kronenberg","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(18)32261-X","article-title":"Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): A double-blind, randomised placebo-controlled trial","volume":"392","author":"Hernandez","year":"2018","journal-title":"Lancet"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.2337\/dc23-S009","article-title":"9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes\u20142023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/eurjpc\/zwab212","article-title":"Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"29","author":"Alon","year":"2022","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_81","first-page":"e25495","article-title":"Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease","volume":"14","author":"Hassen","year":"2022","journal-title":"Cureus"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1161\/ATV.0000000000000153","article-title":"Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement from the American Heart Association","volume":"42","author":"Duell","year":"2022","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): A multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong","year":"2016","journal-title":"Lancet"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","article-title":"A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis","volume":"384","author":"Newsome","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Cho, Y., Rhee, H., Kim, Y.-E., Lee, M., Lee, B.-W., Kang, E.S., Cha, B.-S., Choi, J.-Y., and Lee, Y.-H. (2022). Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: An open-label randomized controlled trial (ESSENTIAL study). BMC Med., 20.","DOI":"10.1186\/s12916-022-02288-2"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.atherosclerosis.2008.08.009","article-title":"Predictive value of coronary artery stenoses and C-reactive protein levels in patients with stable coronary artery disease","volume":"204","author":"Avanzas","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/clinchem\/hvaa275","article-title":"Inflammation in Atherosclerosis\u2014No Longer a Theory","volume":"67","author":"Libby","year":"2021","journal-title":"Clin. Chem."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/eurheartj\/ehaa099","article-title":"Targeting cardiovascular inflammation: Next steps in clinical translation","volume":"42","author":"Lawler","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1016\/j.ijcard.2013.07.113","article-title":"High-sensitivity C-reactive protein and atherosclerotic disease: From improved risk prediction to risk-guided therapy","volume":"168","author":"Koenig","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1161\/CIRCULATIONAHA.115.018381","article-title":"Achievement of dual low-density lipo- protein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT","volume":"132","author":"Bohula","year":"2015","journal-title":"Circulation"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/CIRCULATIONAHA.118.034032","article-title":"Inflammatory and cholesterol risk in the FOURIER trial","volume":"138","author":"Bohula","year":"2018","journal-title":"Circulation"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","article-title":"Effect of interleukin-1beta inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: Exploratory results from a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Ridker","year":"2017","journal-title":"Lancet"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMoa1809798","article-title":"Low-Dose Methotrexate for the Prevention of Atherosclerotic Events","volume":"380","author":"Ridker","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in Patients with Chronic Coronary Disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1093\/eurheartj\/ehy267","article-title":"The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: A meta-analysis focused on post-test disease probability","volume":"39","author":"Knuuti","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM197906143002402","article-title":"Analysis of Probability as an Aid in the Clinical Diagnosis of Coronary-Artery Disease","volume":"300","author":"Diamond","year":"1979","journal-title":"N. Engl. J. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/ehjci\/jey182","article-title":"Pretest probability for patients with suspected obstructive coronary artery disease: Re-evaluating Diamond-Forrester for the contemporary era and clinical implications: Insights from the PROMISE trial","volume":"20","author":"Foldyna","year":"2018","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.jcmg.2018.06.021","article-title":"Comparison of International Guidelines for Assessment of Suspected Stable Angina: Insights from the PROMISE and SCOT-HEART","volume":"11","author":"Adamson","year":"2018","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/ehjci\/jez054","article-title":"Impact of a decreasing pre-test probability on the performance of diagnostic tests for coronary artery disease","volume":"20","author":"Saraste","year":"2019","journal-title":"Eur. Heart J.\u2014Cardiovasc. Imaging"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMoa0807611","article-title":"Fractional flow reserve versus angiography for guiding percutaneous coronary intervention","volume":"360","author":"Tonino","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e008487","DOI":"10.1161\/CIRCINTERVENTIONS.119.008487","article-title":"Novel Indices of Coronary Physiology: Do We Need Alternatives to Fractional Flow Reserve?","volume":"13","author":"Scarsini","year":"2020","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Committee Members, Gibbons, R.J., Balady, G.J., Bricker, J.T., Chaitman, B.R., Fletcher, G.F., Froelicher, V.F., Mark, D.B., McCallister, B.D., and Mooss, A.N. (2002). ACC\/AHA 2002 guideline update for exercise testing: Summary article: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation, 106, 1883\u20131892.","DOI":"10.1161\/01.CIR.0000034670.06526.15"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1161\/CIRCRESAHA.116.307914","article-title":"Fractional Flow Reserve and Coronary Computed Tomographic Angiography: A Review and Critical Analysis","volume":"119","author":"Hecht","year":"2016","journal-title":"Circ. Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.jcmg.2023.02.005","article-title":"The Use and Efficacy of FFR-CT: Real-World Multicenter Audit of Clinical Data with Cost Analysis. JACC Cardiovasc Imaging","volume":"16","author":"Mittal","year":"2023","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"e012652","DOI":"10.1136\/bmjopen-2016-012652","article-title":"Cost-effectiveness of anatomical and functional test strategies for stable chest pain: Public health perspective from a middle-income country","volume":"7","author":"Bertoldi","year":"2017","journal-title":"BMJ Open"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"e2028312","DOI":"10.1001\/jamanetworkopen.2020.28312","article-title":"Cost-effectiveness Analysis of Anatomic vs Functional Index Testing in Patients With Low-Risk Stable Chest Pain","volume":"3","author":"Mayrhofer","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/ehjqcco\/qcw029","article-title":"Comparative cost-effectiveness of non-invasive imaging tests in patients presenting with chronic stable chest pain with suspected coronary artery disease: A systematic review","volume":"2","author":"Khanji","year":"2016","journal-title":"Eur. Heart J.\u2014Qual. Care Clin. Outcomes"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"e001700","DOI":"10.1136\/openhrt-2021-001700","article-title":"Cost-effectiveness in diagnosis of stable angina patients: A decision-analytical modelling approach","volume":"9","author":"Nazir","year":"2022","journal-title":"Open Heart"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/j.jacc.2010.03.007","article-title":"Long-Term Outcome of a Routine versus Selective Invasive Strategy in Patients With Non\u2013ST-Segment Elevation Acute Coronary Syndrome: A Meta-Analysis of Individual Patient Data","volume":"55","author":"Fox","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.jacc.2006.06.050","article-title":"Benefit of Early Invasive Therapy in Acute Coronary Syndromes: A Meta-Analysis of Contemporary Randomized Clinical Trials","volume":"48","author":"Bavry","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal Medical Therapy with or without PCI for Stable Coronary Disease","volume":"356","author":"Boden","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"BARI 2D Study Group, Frye, R.L., August, P., Brooks, M.M., Hardison, R.M., Kelsey, S.F., MacGregor, J.M., Orchard, T.J., Chaitman, B.R., and Genuth, S.M. (2009). A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease. N. Engl. J. Med., 360, 2503\u20132515.","DOI":"10.1056\/NEJMoa0805796"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1205361","article-title":"Fractional Flow Reserve\u2013Guided PCI versus Medical Therapy in Stable Coronary Disease","volume":"367","author":"Pijls","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(17)32714-9","article-title":"Percutaneous coronary intervention in stable angina (ORBITA): A double-blind, randomised controlled trial","volume":"391","author":"Thompson","year":"2018","journal-title":"Lancet"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/CIRCULATIONAHA.122.062714","article-title":"Survival After Invasive or Conservative Management of Stable Coronary Disease","volume":"147","author":"Hochman","year":"2023","journal-title":"Circulation"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/jamacardio.2020.1251","article-title":"Complete vs culprit-lesion-only revascularization for ST-segment elevation myocardial infarction: A systematic review and meta-analysis","volume":"5","author":"Bainey","year":"2020","journal-title":"JAMA Cardiol."},{"key":"ref_120","unstructured":"Writing Committee Members, Lawton, J.S., Tamis-Holland, J.E., Bangalore, S., Bates, E.R., Beckie, T.M., Bischoff, J.M., Bittl, J.A., Cohen, M.G., and DiMaio, J.M. (2022). 2021 ACC\/AHA\/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J. Am. Coll. Cardiol., 79, e21\u2013e129."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJMoa2104650","article-title":"Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction","volume":"385","author":"Puymirat","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jcin.2022.01.002","article-title":"FFR-Versus Angiography-Guided Revascularization for Nonculprit Stenosis in STEMI and Multivessel Disease. A Network Meta-Analysis","volume":"15","author":"Elbadawi","year":"2022","journal-title":"J. Am. Coll. Cardiovasc. Interv."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJMoa1100356","article-title":"Coronary-Artery Bypass Surgery in Patients with Left Ventricular Dysfunction","volume":"364","author":"Velazquez","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJMoa2206606","article-title":"Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction","volume":"387","author":"Perera","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jcin.2019.09.033","article-title":"Effect of Intravascular Ultrasound\u2013Guided Drug-Eluting Stent Implantation: 5-Year Follow-Up of the IVUS-XPL Randomized Trial","volume":"13","author":"Hong","year":"2020","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jcin.2020.10.001","article-title":"3-Year Outcomes of the ULTIMATE Trial Comparing Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation","volume":"14","author":"Gao","year":"2021","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_127","first-page":"578","article-title":"Long term health outcome and mortality evaluation after invasive coronary treatment using drug eluting stents with or without the IVUS guidance","volume":"75","author":"Jager","year":"2010","journal-title":"Randomized control trial. HOME DES IVUS. Catheter. Cardiovasc. Interv."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ahj.2012.09.017","article-title":"A prospective, randomized trial of intravascular-ultrasound guided compared to angiography guided stent implantation in complex coronary lesions: The AVIO trial","volume":"165","author":"Chieffo","year":"2013","journal-title":"Am. Heart J."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/S0140-6736(20)32236-4","article-title":"Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): A randomised, open-label, phase 3b trial","volume":"396","author":"Silvain","year":"2020","journal-title":"Lancet"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"e008649","DOI":"10.1161\/CIRCINTERVENTIONS.119.008649","article-title":"Randomized Comparison of Intensified and Standard P2Y12-Receptor-Inhibition Before Elective Percutaneous Coronary Intervention: The SASSICAIA Trial","volume":"13","author":"Mehilli","year":"2020","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Shepperd, S., Lannin, N.A., Clemson, L.M., McCluskey, A., Cameron, I.D., and Barras, S.L. (2013). Discharge planning from hospital to home. Cochrane Database Syst. Rev.","DOI":"10.1002\/14651858.CD000313.pub4"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Luc\u00e0, F., Oliva, F., Rao, C.M., Abrignani, M.G., Amico, A.F., Di Fusco, S.A., Caretta, G., Di Matteo, I., Di Nora, C., and Pilleri, A. (2023). Management and Quality, Cronicity, Cardiovascular Prevention Working Groups of the Italian Association of Hospital Cardiologists (ANMCO). Appropriateness of Dyslipidemia Management Strategies in Post-Acute Coronary Syndrome: A 2023 Update. Metabolites, 13.","DOI":"10.3390\/metabo13080916"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"200198","DOI":"10.1016\/j.ijcrp.2023.200198","article-title":"Residual cardiovascular risk, use of standard care treatments, and achievement of treatment goals in patients with cardiovascular disease","volume":"18","author":"Siniawski","year":"2023","journal-title":"Int. J. Cardiol. Cardiovasc. Risk Prev."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/18\/5989\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:51:43Z","timestamp":1760129503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/18\/5989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,15]]},"references-count":133,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["jcm12185989"],"URL":"https:\/\/doi.org\/10.3390\/jcm12185989","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,15]]}}}